Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

unknown267%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell Carcinoma

NCT05806073
unknownphase_4

The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor

NCT03017053
unknownnot_applicable

Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell Carcinoma

NCT01334320

Clinical Trials (3)

Showing 3 of 3 trials
NCT05806073Not Applicable

Elective vs Therapeutic Neck Dissection in Treatment of Patients With Clinical T1/2N1M0 Oral Squamous Cell Carcinoma

Not Yet Recruiting
NCT03017053Phase 4

The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor

Unknown
NCT01334320Not Applicable

Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell Carcinoma

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3